Eli Lilly and Company: all 2,262 studies
Page 21 of 23. Open to participants first (177), then studies with results posted, then the rest; newest registration first within each.
- Comparison of Two Growth Hormone Dosing Methods in Adults With Growth Hormone DeficiencyCompletedNCT00490191Phase 4
- Trial Comparing 3 and 4 Week Regimen of Gemcitabine and Cisplatin in Patients With Lung CancerCompletedNCT00489996Phase 2
- Trial of Pemetrexed or Pemetrexed With Gemcitabine for Patients With Advanced Lung Cancer Who Are Not Eligible for Platinum-Based Chemotherapy and Have Not Previously Been Treated With ChemotherapyCompletedNCT00489983Phase 2
- Duloxetine Versus Paroxetine for Major DepressionCompletedNCT00489775Phase 3
- Duloxetine Versus Placebo for FibromyalgiaCompletedNCT00489073Phase 3
- Evaluation of Continuous Symptom Treatment of ADHDCompletedNCT00486122Phase 4
- Comparison Atomoxetine Hydrochloride and Comparator in Pediatric Outpatients With ADHDCompletedNCT00486083Phase 3
- Weight Gain Management in Patients With SchizophreniaCompletedNCT00486005Phase 4
- Comparison of Intramuscular Olanzapine and Intramuscular Haloperidol in Patients With SchizophreniaCompletedNCT00485901Phase 3
- Safety and Efficacy of Switching From a Stimulant Medication to Atomoxetine in Children and Adolescents With ADHDCompletedNCT00485875Phase 4
- Combination Therapy in Patients With DepressionCompletedNCT00485862Phase 4
- A Study of Atomoxetine for Attention Deficit and Hyperactive/Impulsive Behaviour Problems in Children With ASDCompletedNCT00485849Phase 4
- Assessment of a Weight Management Program for Weight Gain in Patients With SchizophreniaCompletedNCT00485823Phase 4
- Examining Rapid Acting Intra-Muscular Olanzapine in Japanese Patients With SchizophreniaCompletedNCT00485810Phase 1/2
- Olanzapine/Fluoxetine Combination Versus Comparator in the Treatment of Bipolar I DepressionCompletedNCT00485771Phase 4
- Olanzapine Versus Comparator in the Treatment of Bipolar DisorderCompletedNCT00485680Phase 3
- Safety Study in Outpatient Japanese Children With ADHDCompletedNCT00485628Phase 2
- Comparison of Atomoxetine Plus Either Comparator or Placebo in Children With ADHD Who Haven't Responded to Stimulant TherapyCompletedNCT00485550Phase 3
- Managing Acute Schizophrenia, a Comparison Between Two Atypical AntipsychoticsCompletedNCT00485498Phase 4
- Atomoxetine Hydrochloride Versus Placebo in Taiwanese Children and Adolescents With ADHDCompletedNCT00485459Phase 3
- Guiding Dose Increases in Patients Incompletely Responsive to Usual Doses of AtomoxetineCompletedNCT00485407Phase 3
- Safety, Tolerability, and Effect of LY2405319 After Multiple Injections in Subjects With Type 2 DiabetesCompletedNCT00481117Phase 1
- Lilly's Emotional and Physical Symptoms of Depression Study (LEAPS)CompletedNCT00479726Phase 4
- Duloxetine vs Placebo in the Treatment of General AnxietyCompletedNCT00475969Phase 3
- Urge Incontinence Bladder Overactivity StudyCompletedNCT00475696Phase 2
- Duloxetine Stress Urinary Incontinence Efficacy and Safety StudyCompletedNCT00475397Phase 3
- Efficacy and Safety Stress Urinary Incontinence StudyCompletedNCT00475358Phase 3
- A Study of Enzastaurin in Patients With LeukemiaCompletedNCT00452257Phase 1
- A Study for Patients With Type 1 Diabetes MellitusCompletedNCT00447213Phase 2/3
- Evaluate the Efficacy and Safety of Insulin Compared to Glargine in Patients With Type 2 DiabetesCompletedNCT00437112Phase 3
- Effect of Tadalafil on the Quality of Life and Sexual Life in Erectile DysfunctionCompletedNCT00422578Phase 4
- Efficacy and Safety of Tadalafil in Subjects With Erectile Dysfunction Caused by Spinal Cord InjuryCompletedNCT00421083Phase 3
- A Study of LY2181308 in Patients With Advanced Hepatocellular CarcinomaWithdrawnNCT00415155Phase 1/2
- Evaluation of the Effects of Duloxetine on NorepinephrineCompletedNCT00414323Phase 1
- The Effect of Growth Hormone in Very Young Girls With Turner SyndromeCompletedNCT00406926Phase 3
- Compare Two Dosing Algorithms in Insulin-Naive Patients With Type 2 Diabetes MellitusCompletedNCT00391209Phase 3
- Safety Confirmation Study of Pemetrexed Plus Cisplatin in Patients With Malignant Pleural MesotheliomaCompletedNCT00386815Phase 2
- Efficacy, Tolerability, and Safety of Once-Daily Atomoxetine Hydrochloride Versus Placebo in Russian Children and Adolescents With Attention-Deficit/Hyperactivity DisorderCompletedNCT00386581Phase 3
- Enzastaurin For Breast Cancer Patients Who Previously Received an Anthracycline and a Taxane ChemotherapyCompletedNCT00386087Phase 2
- Study Comparing Arzoxifene With Raloxifene in Women After Menopause With OsteoporosisCompletedNCT00383422Phase 3
- A Study of Semen Characteristics After 9 Months of Daily Tadalafil 20 mgCompletedNCT00382135Phase 4
- A Study to Evaluate the Efficacy and Safety of 2.5mg and 5mg Tadalafil Given Once a Day to Men With Erectile DysfunctionCompletedNCT00381732Phase 3
- A Study in People With Mild HypertensionCompletedNCT00374855Phase 2
- A Phase II Study of Cetuximab Plus Irinotecan in Patients With EGFR-detectable Metastatic Colorectal CarcinomaCompletedNCT00362102Phase 2
- Evaluate the Efficacy of Insulin Patients With Type 1 DiabetesCompletedNCT00356109Phase 3
- Evaluate the Efficacy and Safety of Insulin in Patients With Type 2 DiabetesCompletedNCT00355849Phase 3
- A Study of Visual Effects of Erectile Dysfunction Medications Dosed Daily for Six MonthsCompletedNCT00333281Phase 4
- Study of Hot Flashes and Night Sweats in Postmenopausal Women Receiving Combination Raloxifene and Oral EstrogenCompletedNCT00332553Phase 2
- A Concordance Study Comparing Insulin Treatments in Patients With Type 2 DiabetesCompletedNCT00330473Phase 3
- Effects of LY2062430 in Subjects With Mild-to-Moderate Alzheimer's Disease and in Healthy VolunteersCompletedNCT00329082Phase 2
- Study of Human Insulin Inhalation Powder in Patients With Type 2 DiabetesCompletedNCT00325364Phase 3
- Patient's Preference Between Conventional Oral Olanzapine Tablet vs Olanzapine Orodispersible TabletCompletedNCT00324051Phase 4
- A Study Using Rapid Acting Intramuscular Olanzapine in Agitated Patients With SchizophreniaCompletedNCT00316238Phase 2
- Observational Study of Pergolide Mesylate and Cardiac ValvulopathyCompletedNCT00311532
- Enzastaurin Versus Lomustine in GlioblastomaCompletedNCT00295815Phase 3
- Tolerability of Switching to Duloxetine for the Management of Diabetic Nerve PainCompletedNCT00266643Phase 4
- Efficacy Study of LY2422347 to Treat InsomniaCompletedNCT00259311Phase 2
- Study of Pemetrexed Plus Cisplatin in Patients With Malignant Pleural MesotheliomaCompletedNCT00251550Phase 1/2
- Effects of LY450139 Dihydrate on Subjects With Mild to Moderate Alzheimer's DiseaseCompletedNCT00244322Phase 2
- To Determine How Effective Duloxetine is in Treating Women 65 Years and Older With Symptoms of Stress Urinary Incontinence, or With a Combination of Stress Urinary Incontinence and Urge Urinary Incontinence SymptomsCompletedNCT00244296Phase 4
- Teriparatide and Strontium Ranelate Head-To-Head Comparison TrialCompletedNCT00239629Phase 4
- Duloxetine Versus Placebo in the Treatment of FMSCompletedNCT00233025Phase 3
- Complaints Associated With Use of Pre-Filled Pen B With Type 2 Diabetics on Twice-Daily InsulinCompletedNCT00231725Phase 3
- Neuropsychological Functioning in Children With Attention-Deficit/Hyperactivity Disorder.CompletedNCT00216918Phase 4
- An Exploratory Pharmacogenomic Study of Monotherapy Erbitux in Subjects With Metastic Colorectal CancerCompletedNCT00207155Phase 1
- An Exploratory Pharmacogenomic Study of Monotherapy Erbitux in Subjects With Metastatic Non Small Cell Lung CarcinomaCompletedNCT00207116Phase 1
- Study of Cetuximab in Combination With Tarceva in Patients With Solid TumorsCompletedNCT00207077Phase 1
- Gemcitabine Plus Cisplatin Single Dose Versus Split Dose in the Treatment of Patients With Locally Advanced or Metastatic Breast Cancer After Failure of Anthracyclines and/or TaxanesCompletedNCT00192101Phase 2
- A Study of Pemetrexed Plus Oxaliplatin as First Line Therapy in Advanced Gastric CarcinomaCompletedNCT00192088Phase 2
- A Trial of Gemcitabine Combined With Vinorelbine as First Line Chemotherapy for Metastatic Breast CancerCompletedNCT00192062Phase 2
- A Randomized Study Comparing Single Agent Gemcitabine Intravesical Therapy Versus Mitomycin C in Patients With Intermediate Risk Superficial Bladder CancerCompletedNCT00192049Phase 2
- Optimal Length of Treatment Continuation With Olanzapine After Remission of Manic or Mixed EpisodeCompletedNCT00191997Phase 4
- 2nd Line Gemcitabine Monotherapy for Transitional Cell Carcinoma of Urothelium (TCC) After CDDP RegimenCompletedNCT00191971Phase 2
- Switching to Duloxetine From Other AntidepressantsCompletedNCT00191932Phase 4
- A Randomized Double Blind Study Evaluating Duloxetine in Outpatients With MDD and PainCompletedNCT00191919Phase 3
- Bone Effects of Teriparatide Following AlendronateCompletedNCT00191893Phase 3
- Open-Label Trial of Atomoxetine to Evaluate Academic Outcome in Children Ages 8-11 Years With Attention Deficit/Hyperactivity DisorderCompletedNCT00191880Phase 3
- Clinical Trial of Teriparatide in JapanCompletedNCT00191867Phase 2
- Gemcitabine in Combination With Cisplatin as Neoadjuvant NSCLC ChemotherapyCompletedNCT00191841Phase 2
- A Study on Induced Weight Gain During Atypical Antipsychotic Treatment and Its Management With Psychoeducational ProgrammeCompletedNCT00191828Phase 4
- Compliance and Acceptance of Teriparatide Injection in Severely Osteoporotic PatientsCompletedNCT00191802Phase 3
- Neo-Adjuvant Gemcitabine and Cisplatin in Treating Patients With Early Stage of Non Small Cell Lung CancerCompletedNCT00191763Phase 2
- A Study of Pemetrexed in Small Cell Lung Cancer, Which Has ReturnedCompletedNCT00191750Phase 2
- An Open-Label Study of Atomoxetine in Adolescents With Attention-Deficit/Hyperactivity DisorderCompletedNCT00191737Phase 3
- Intravesical Gemcitabine Instillation Followed by Transurethral Resection for the Treatment of Patients With Superficial Bladder Cancer at Low Risk.CompletedNCT00191711Phase 2
- Comparison of Atomoxetine and Placebo in Children and Adolescents With ADHD and ODDCompletedNCT00191698Phase 3
- Duloxetine in the Treatment of Melancholic DepressionCompletedNCT00191685Phase 3
- A Trial Of Gemcitabine Plus Paclitaxel And Gemcitabine Plus Docetaxel In Metastatic Breast CancerCompletedNCT00191672Phase 2
- Study of Broader Efficacy of Atomoxetine in the Treatment of ADHD in Children/AdolescentsCompletedNCT00191659Phase 3
- Study of Atomoxetine in Children With ADHD to Assess Symptomatic and Functional OutcomesCompletedNCT00191633Phase 4
- Study Comparing Short Infusion Vs. Fixed Dose of Cisplatin + Gemcitabine in Non Small Cell Lung Cancer.CompletedNCT00191620Phase 2
- A Randomized Trial for Patients With Platinum Resistant Ovarian, Fallopian or Primary Peritoneal Cancer.CompletedNCT00191607Phase 3
- Open-Label Duloxetine Extension Phase in Patients Who Have Completed Previous Duloxetine TrialsCompletedNCT00191594Phase 3
- Local Registration Trial in China Humalog Mix 50CompletedNCT00191581Phase 3
- Gemcitabine, Oxaliplatin and Radiotherapy in Treating Patients With Completely Resected Pancreatic CancerCompletedNCT00191568Phase 2
- Efficacy Study of Switching Stabilized Schizophrenic Patients From Conventional to Atypical Antipsychotic TreatmentCompletedNCT00191555Phase 4
- Atomoxetine vs Placebo in the Treatment of ADHD in Swedish Children and AdolescentsCompletedNCT00191542Phase 3
- Growth Hormone Treatment in Short Children Born Small for Gestational AgeCompletedNCT00191529Phase 3
- An Open-Label Study of Atomoxetine in Children With Attention-Deficit/Hyperactivity DisorderCompletedNCT00191516Phase 3
- Gemcitabine and Pemetrexed in Primary Unknown AdenocarcinomaCompletedNCT00191503Phase 2